May 1st 2025
Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.
Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.
April 29th 2025
April 24th 2025
AI is transforming content reviews to focus on relevant use, not just generation.
April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
Senate Confirm Califf as FDA Commissioner
February 25, 2016.
CVS Reports "Dramatic" Drop in Prescription Drug Trend
February 23, 2016.
European Patients' Academy Launches R&D Toolbox
February 22, 2016.
UK Pharma Companies Face £45 million in Pay-For-Delay Deal Fines
Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study
February 19, 2016.
Translational Medicine: A “Team Sport”?
February 19, 2016
Asia-Pac Breast Cancer Market to Grow to $3.4 billion by 2021, Says Report
February 18, 2016.
Pharma Smackdown on Capitol Hill
Stakeholders React to England's Cancer Drug Fund Proposals
February 17, 2016.
Wyeth Agrees to $784 Million Medicaid Claim Fine
Vaccines Prove Effective and Cost-Effective
February 11, 2016.
Call for "Multi-Pronged Approach" to Fight Zika Virus
February 16, 2016.
FDA Warning to Cannabidiol Suppliers
February 15, 2016.
PhRMA Unveils New Ads Showing Patient Side of Biopharma Innovation
Little to Like in Obama’s Last Budget
February 12, 2016.
Industry and Patients: An Evolving Partnership
February 09, 2016.
Price to Avoid Vaccine Shortages, Say Researchers
Trial Results Boost Chances for BI Lung Cancer Drug Outside US
Congress to Keep a Close Watch on FDA
February 08, 2016
Negotiating Medicare Part D Prices
Can the feds negotiate Medicare Part D prices? Jill Wechsler reports.
Breakthrough Therapies Challenge FDA Reviewers, Manufacturers
The development of more complex biopharmaceutical therapies that merit accelerated evaluation and approval has put pressure on FDA to speed up its review process.
Sanofi Joins Fight Against Zika Virus
February 04, 2016.
Head and Neck Cancer Market "Will Quadruple" by 2024
Shkreli Braves the Storm
As Mr Shkreli goes to Washington, Casey McDonald considers what the silver screen treatment of this chapter in the pharma bro saga might be like.
Novartis Prepares for "Explosion" of Gleevec Copycats
February 03, 2016.
Sanofi Pasteur Launches Zika Vaccine Project
February 02, 2016.
Amgen "Clears First Regulatory Hurdle for Biosimilar Production"
4A's Partner Awards: Deadline for Entries Extended to February 12
French Bial Trial Death: Regulators Release Timeline of Events
February 01, 2016.
Harvard Business School Launches Precision Trials Challenge
28 January, 2016.